Skip to main content
. 2019 Nov 19;19(1):283–290. doi: 10.3892/ol.2019.11115

Figure 1.

Figure 1.

Growth inhibitory effects of CAP. The OS cell lines, MNNG-HOS and U2-OS, were treated with kINPen MED and MiniJet-R CAP sources, and compared with argon-treated control cells. Proliferation of the (A) U2OS and (B) MNNG/HOS cells treated with kINPen MED was significantly decreased 24 h after treatment and all time points assessed after that. Similar results were observed for the (C) U2OS and (D) MNNG/HOS cells treated with the MiniJet-R device. *P≤0.05, **P≤0.01, ***P≤0.001. CAP, cold atmospheric plasma; OS, osteosarcoma.